Companies / Passage BIO, Inc. / Activity
Activity — Passage BIO, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common Stock | $192.5K | +25K +22.48% | 133,612 4.15% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common Stock | $-148.4K | -13K -100.00% | 0 | low |
| Q1 2026 as of | Nano Cap New Millennium Growth Fund L P 13F manager | Exit | Common Stock | $-118.0K | -10K -100.00% | 0 | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $78.4K | +10K +31.80% | 41,380 1.29% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common Stock | $-4.8K | -993 -3.44% | 27,910 0.87% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | New | Common Stock | $1.7K | +212 | 212 <0.01% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common Stock | $0 | +2 | 2 <0.01% of shares | low |